http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2373581-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_10efc646a4dd605c2f09c493718f5b81 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G09B23-28 |
| filingDate | 2008-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2009-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4cede87e67a376d396cd0c1f92f69ddb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ae46a820466e228b47ae91400868eb49 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ecc727cb926410ad275284b069ebed11 |
| publicationDate | 2009-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2373581-C1 |
| titleOfInvention | Method of simulating amyloidosis in animals |
| abstract | FIELD: medicine. n SUBSTANCE: invention refers to experimental medicine, namely to experimental nephrology and can be used for simulating experimental amyloidosis in animals. That is ensured by subcutaneous introduction of native ovalbumin to old rats every second day at 0.025 ml/g of body weight within 60 days of the experiment. n EFFECT: enhanced simulation of experimental amyloidosis in animals. n 1 ex, 2 tbl, 4 dwg |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2572721-C1 |
| priorityDate | 2008-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 29.